Mary Kay Fenton

2014 - Achillion Pharmaceuticals

In 2014, Mary Kay Fenton earned a total compensation of $1.7M as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 74% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$158,479
Option Awards$1,209,436
Salary$347,679
Other$8,124
Total$1,723,718

Fenton received $1.2M in option awards, accounting for 70% of the total pay in 2014.

Fenton also received $158.5K in non-equity incentive plan, $347.7K in salary and $8.1K in other compensation.

Rankings

In 2014, Mary Kay Fenton's compensation ranked 5,156th out of 13,032 executives tracked by ExecPay. In other words, Fenton earned more than 60.4% of executives.

ClassificationRankingPercentile
All
5,156
out of 13,032
60th
Division
Manufacturing
1,839
out of 4,966
63rd
Major group
Chemicals And Allied Products
609
out of 1,686
64th
Industry group
Drugs
464
out of 1,365
66th
Industry
Pharmaceutical Preparations
371
out of 1,043
64th
Source: SEC filing on April 17, 2017.

Fenton's colleagues

We found four more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2014.

2014

Milind Deshpande

Achillion Pharmaceuticals

Chief Executive Officer

2014

David Apelian

Achillion Pharmaceuticals

Chief Medical Officer

2014

Joseph Truitt

Achillion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2014

Gautam Shah

Achillion Pharmaceuticals

Former Executive Vice President and Chief Compliance Officer

News

In-depth

You may also like